Saroja Pharma In

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0PCL01011
  • NSEID: SAROJA
  • BSEID:
INR
39.40
-1.8 (-4.37%)
BSENSE

Dec 05

BSE+NSE Vol: 3200

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Saroja Pharma Industries India Ltd stock-summary
stock-summary
Saroja Pharma Industries India Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of "Saroja Pharma Industries India Private Limited" on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra. Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to "Saroja Pharma Industries India Limited" through fresh Certificate of Incorporation dated April 18, 2023.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 4.02 Cr
Number of Shares
40.2 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
08-Sep-2023
40.2
4.02
1084800
10
Public Issue
09-Feb-2023
29.36
2.94
2709864
10
Bonus Issue
28-Feb-2022
2.26
0.23
15822
10
Preferential Allotment
23-Jun-2021
2.1
0.21
200000
10
Right Issues
14-Jan-2019
1
0.01
10000
10
Subscriber to MOA
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Biju Gopinathan Nair (72.05%)

Highest Public shareholder

Swastika Investmart Ltd (1.87%)

Individual Investors Holdings

23.6%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
48.2778
0%
 
100
Cost of Materials Consumed
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00